Meal replacement sales will decline sharply in 2025 as consumers trade calorie-restrictive meal systems for nutrient-packed offerings
This is the most common question I hear from clients who have recently started semaglutide or tirzepatide
For those who require maximal weight loss, such as people managing severe obesity alongside cardiovascular risk or obstructive sleep apnoea, injectable therapy may remain the medically preferred route
(2023) type 2 diabetes study
The following is a brief overview of clinical trial data available to date
A smarter approach by Congress Even well-intentioned senators like Bernie Sanders, Elizabeth Warren, and Dick Durbin who are doing a good initial job of digging into GLP-1 policy may not fully grasp the systemwide, whole of government approach that is needed to harness this medical revolution in a way that puts patients, and patient safety, first